These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32525297)

  • 1. Optimization of High-Throughput Methyltransferase Assays for the Discovery of Small Molecule Inhibitors.
    Dong G; Yasgar A; Peterson DL; Zakharov A; Talley D; Cheng KC; Jadhav A; Simeonov A; Huang R
    ACS Comb Sci; 2020 Aug; 22(8):422-432. PubMed ID: 32525297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct High-Throughput Screening Assay for mRNA Cap Guanine-N7 Methyltransferase Activity.
    Kasprzyk R; Fido M; Mamot A; Wanat P; Smietanski M; Kopcial M; Cowling VH; Kowalska J; Jemielity J
    Chemistry; 2020 Sep; 26(49):11266-11275. PubMed ID: 32259329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamer Displacement Screen for Flaviviral RNA Methyltransferase Inhibitors.
    Falk SP; Weisblum B
    J Biomol Screen; 2014 Sep; 19(8):1147-53. PubMed ID: 24793430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2.
    Coussens NP; Kales SC; Henderson MJ; Lee OW; Horiuchi KY; Wang Y; Chen Q; Kuznetsova E; Wu J; Chakka S; Cheff DM; Cheng KC; Shinn P; Brimacombe KR; Shen M; Simeonov A; Lal-Nag M; Ma H; Jadhav A; Hall MD
    J Biol Chem; 2018 Aug; 293(35):13750-13765. PubMed ID: 29945974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A universal fluorescence polarization high throughput screening assay to target the SAM-binding sites of SARS-CoV-2 and other viral methyltransferases.
    Samrat SK; Bashir Q; Zhang R; Huang Y; Liu Y; Wu X; Brown T; Wang W; Zheng YG; Zhang QY; Chen Y; Li Z; Li H
    Emerg Microbes Infect; 2023 Dec; 12(1):2204164. PubMed ID: 37060263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus.
    Lim SV; Rahman MB; Tejo BA
    BMC Bioinformatics; 2011; 12 Suppl 13(Suppl 13):S24. PubMed ID: 22373153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of specific dengue virus 2'-O- and N7-methyltransferase assays for antiviral drug screening.
    Barral K; Sallamand C; Petzold C; Coutard B; Collet A; Thillier Y; Zimmermann J; Vasseur JJ; Canard B; Rohayem J; Debart F; Decroly E
    Antiviral Res; 2013 Sep; 99(3):292-300. PubMed ID: 23769894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyltransferase-Glo: a universal, bioluminescent and homogenous assay for monitoring all classes of methyltransferases.
    Hsiao K; Zegzouti H; Goueli SA
    Epigenomics; 2016 Mar; 8(3):321-39. PubMed ID: 26950288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery.
    Coutard B; Decroly E; Li C; Sharff A; Lescar J; Bricogne G; Barral K
    Antiviral Res; 2014 Jun; 106():61-70. PubMed ID: 24704437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potent DOT1L inhibitors by AlphaLISA based High Throughput Screening assay.
    Song Y; Li L; Chen Y; Liu J; Xiao S; Lian F; Zhang N; Ding H; Zhang Y; Chen K; Jiang H; Zhang C; Liu YC; Chen S; Luo C
    Bioorg Med Chem; 2018 May; 26(8):1751-1758. PubMed ID: 29534934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sensitive luminescent assay for the histone methyltransferase NSD1 and other SAM-dependent enzymes.
    Drake KM; Watson VG; Kisielewski A; Glynn R; Napper AD
    Assay Drug Dev Technol; 2014 Jun; 12(5):258-71. PubMed ID: 24927133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yeast-based assays for the high-throughput screening of inhibitors of coronavirus RNA cap guanine-N7-methyltransferase.
    Sun Y; Wang Z; Tao J; Wang Y; Wu A; Yang Z; Wang K; Shi L; Chen Y; Guo D
    Antiviral Res; 2014 Apr; 104():156-64. PubMed ID: 24530452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Throughput Screening and Triage Assays Identify Small Molecules Targeting c-MYC in Cancer Cells.
    Kallal LA; Waszkiewicz A; Jaworski JP; Della Pietra A; Berrodin T; Brady P; Jurewicz AJ; Zeng X; Payne L; Medina JR; Doepner-Buser C; Mangatt B
    SLAS Discov; 2021 Feb; 26(2):216-229. PubMed ID: 33482073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemiluminescence Immunoassay for S-Adenosylhomocysteine Detection and Its Application in DNA Methyltransferase Activity Evaluation and Inhibitors Screening.
    Li X; Meng M; Zheng L; Xu Z; Song P; Yin Y; Eremin SA; Xi R
    Anal Chem; 2016 Sep; 88(17):8556-61. PubMed ID: 27464505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of structurally-diverse inhibitor scaffolds by high-throughput screening of a fragment library with dimethylarginine dimethylaminohydrolase.
    Linsky TW; Fast W
    Bioorg Med Chem; 2012 Sep; 20(18):5550-8. PubMed ID: 22921743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Small-Molecule Inhibitors of Neutral Ceramidase (nCDase) via Target-Based High-Throughput Screening.
    Otsuka Y; Airola MV; Choi YM; Coant N; Snider J; Cariello C; Saied EM; Arenz C; Bannister T; Rahaim R; Hannun YA; Shumate J; Scampavia L; Haley JD; Spicer TP
    SLAS Discov; 2021 Jan; 26(1):113-121. PubMed ID: 32734807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-guided DOT1L probe optimization by label-free ligand displacement.
    Yi JS; Federation AJ; Qi J; Dhe-Paganon S; Hadler M; Xu X; St Pierre R; Varca AC; Wu L; Marineau JJ; Smith WB; Souza A; Chory EJ; Armstrong SA; Bradner JE
    ACS Chem Biol; 2015 Mar; 10(3):667-74. PubMed ID: 25397901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AlphaScreen-Based Assays: Ultra-High-Throughput Screening for Small-Molecule Inhibitors of Challenging Enzymes and Protein-Protein Interactions.
    Yasgar A; Jadhav A; Simeonov A; Coussens NP
    Methods Mol Biol; 2016; 1439():77-98. PubMed ID: 27316989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in profiling and lead optimization of drug discovery for methyltransferases.
    Horiuchi KY
    Drug Discov Today Technol; 2015 Nov; 18():62-8. PubMed ID: 26723894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the Type II Secretion System: Development, Optimization, and Validation of a High-Throughput Screen for the Identification of Small Molecule Inhibitors.
    Waack U; Johnson TL; Chedid K; Xi C; Simmons LA; Mobley HLT; Sandkvist M
    Front Cell Infect Microbiol; 2017; 7():380. PubMed ID: 28894700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.